We've found
6,570 Prostate Cancer
clinical trials
Oncology Clinical Trial
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Castration-Resistant Prostatic Neoplasms Clinical Trial
A Study of JNJ-63723283, a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Castration-Resistant Prostatic Neoplasms Clinical Trial
A Study of JNJ-63723283, a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Trial of eRapa in Prostate Cancer Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 5/28/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
6,570 Prostate Cancer
clinical trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
Updated: 12/31/1969
68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Castration-Resistant Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of JNJ-63723283, a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Castration-Resistant Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
A Study of JNJ-63723283, a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Trial of eRapa in Prostate Cancer Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Updated: 12/31/1969
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Updated: 12/31/1969
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Updated: 12/31/1969
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Updated: 12/31/1969
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Adenocarcinoma of the Prostate Clinical Trial
Updated: 12/31/1969
Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 12/31/1969
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 5/28/2015
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
I
Updated: 5/28/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/23/2017
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 3/23/2017
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Updated: 12/31/1969
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 10/31/2013
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 6/19/2014
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 6/19/2014
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Integrated Cancer Repository for Cancer Research
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Updated: 9/23/2015
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
Status: Enrolling,
Phase
III
Updated: 9/23/2015
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials